CAS RN: 13358-73-1

DIBUTYLCARBAMYL CHLORIDE

Product Availability

Choose a grade to view its available package options.

4 package records4 with current stock2 grade groups
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20250623 1g In stock Inquiry
Batchno.20260426 250mg In stock Inquiry
Batchno.20260222 50mg In stock Inquiry
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20250813 100mg / 250mg / 1g / 5g Confirm by inquiry Shanghai Inquiry
  • Product code: starshine_CAS13358-73-1
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

13358-73-1 / N,N-dibutylcarbamoyl chloride

Standard CAS: 13358-73-1 Multi CAS: No

Basic Information

CAS
13358-73-1
Multi CAS
No
Molecular Formula
C9H18ClNO
Molecular Weight
191.700000
Exact Mass
191.107692
SMILES
CCCCN(CCCC)C(=O)Cl
InChI
InChI=1S/C9H18ClNO/c1-3-5-7-11(9(10)12)8-6-4-2/h3-8H2,1-2H3
InChIKey
OSWBZCCZJXCOGL-UHFFFAOYSA-N

Computed Properties

Structural Parameters

Heavy atom count
12
Fraction Csp3
0.89
Rotatable bonds
6
H-bond acceptors
1
Molar refractivity
52.64
TPSA
20.31

LogP / Solubility

WLOGP
3.25
MLOGP
2.86
XLogP3
3.3
Consensus LogP
3.14
Log S (ESOL)
-2.68
Class (ESOL)
Moderately soluble
Log S (Ali)
-3.48
Class (Ali)
Poorly soluble
Log S (SILICOS-IT)
-4.32
Class (SILICOS-IT)
Slightly soluble

ADME

GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-1.58

Drug-likeness / Medicinal Chemistry

Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
No
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
1.5

Safety & Transport

Pictogram(s)
Corrosive
Signal
Danger
GHS Hazard Statements
H314 (100%): Causes severe skin burns and eye damage [Danger Skin corrosion/irritation] H318 (100%): Causes serious eye damage [Danger Serious eye damage/eye irritation]
Precautionary Statement Codes
P260, P264, P264+P265, P280, P301+P330+P331, P302+P361+P354, P304+P340, P305+P354+P338, P316, P317, P321, P363, P405, and P501

Get In Touch

Contact Us